Novel Pt@BSA nanoparticles improve radiotherapeutic outcomes in breast cancer
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
We designed a novel nanoplatform, Pt@BSA-RM, that is capable of sensitizing breast cancer cells to radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biomimetic strategies, including cell membrane-coated nanoparticles, were reported to enhance circulation time and immune evasion [34,44,50,56].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-atomic-number (high-Z) nanoplatforms based on silver (Z = 47), gadolinium (Z = 64), platinum (Z = 78), gold (Z = 79), and bismuth (Z = 83) enhance radiation-induced energy deposition through photoelectric interactions and secondary electron generation [15,20,27,28,30,33,34,36,50,63].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multimodal therapeutic approaches were also described, combining radiotherapy with chemotherapy, photothermal therapy, photodynamic therapy, or immunomodulatory strategies [39,43,49,50,67,68,69].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone [17,20,39,40,43,50,63,80].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“Additional findings included decreased cell viability and increased apoptosis following combined nanoparticle and radiotherapy treatment [20,27,33,50,59,72].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [50]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
How to calculate sample size in animal studies?
Charan, J., & Kantharia, N. D. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.119726 · Cited by 1,881
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Li, F.-L., Liu, J.-P., Bao, R.-X., Yan, G., Feng, X., Xu, Y.-P., Sun, Y.-P., Yan, W., Ling, Z.-Q., Xiong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02950-5 · Cited by 196
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance
Song, J., Yang, P. X., Chen, C., Ding, W., Tillement, O., Bai, H., & Zhang, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02266-z · Cited by 186
Lu, L., Dong, J., Wang, L., Xia, Q., Zhang, D., Kim, H., Yin, T., Fan, S., & Shen, Q. (2018) · Oncogene · doi:10.1038/s41388-018-0340-y · Cited by 166
Goodman, C. R., Seagle, B.-L. L., Friedl, T. W. P., Rack, B., Lato, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0163 · Cited by 143
Zhang, X., Zhang, M., Cong, Q., Zhang, M., Zhang, M., Lu, Y., & Xu, C. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.010 · Cited by 141
Tumor Cell Radiosensitivity Is a Major Determinant of Tumor Response to Radiation
Gerweck, L. E., Vijayappa, S., Kurimasa, A., Ogawa, K., & Chen, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0533 · Cited by 106
Provision of Prosthetic Services Following Lower Limb Amputation in Malaysia
Department of Biomedical Engineering, F. O. E. U. O. M., Arifin, N., Hasbollah, H. R., Faculty of Hospitality, T., Hanafi, M. H., Department of Neurosciences, S. O. M. S., Center for Neuroscience Services and Research, U. S. M. H. C., Ibrahim, A. H., Orthopedic Department, U. S. M. H., Wan Abdul Rahman, W. A., et al. (2017) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2017.24.5.12 · Cited by 98
Research works printed but not linked: 1
- Judge, 2015, Am. J. Physiol., 309, L879
Cited by
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
Mohammad, H., Darwish, M., Katona, G., & Csóka, I. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119907
Nanoparticle‐Based Radiosensitizers in Cancer Therapy: Current Advances and Clinical Prospects
Sandu, R., Doddi, T., Maddila, J. R., & Rengan, A. K. (2026) · Advanced Therapeutics · doi:10.1002/adtp.70171
Metadata
- Authors
- Zhang, Y., Liu, Y., & Zheng, D.
- Affiliations
- Ningxia Hui Autonomous Region Peoples Hospital (CN)
- Corresponding author
- Zhang, Yuhui
- Venue
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2026
- Volume
- 17
- Issue
- 2
- Pages
- 1187-1199
- ISSN
- 2632-8682 (ISSN-L)
- OpenAlex
- W7124459104
- Cited by
- 3
- References
- 36
- Citations by year
- 2026: 3
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- Locations
- RSC Medicinal Chemistry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Ningxia Province (2023AAC03448)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- platinum nanoparticles, bovine serum albumin, red blood cell membrane coating, breast cancer, radiotherapy, radiosensitization, X-ray irradiation, tumor growth inhibition, systemic toxicity, biomimetic nanoplatform
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.